A study on round ring patches of skin its causes and treatment.

Phase 2

Completed

• Conditions: Dermatophytosis, unspecified,

• Registration Number: CTRI/2020/07/026503
• Lead Sponsor: National Institute of Ayurveda

Brief Summary

*Dadru* involves the clinical features like *Kandu*, *Deerghapratana*, *Utsanna*,

*Mandala*, *Raaga*, *Pidakas*, which exhibits involvementof *Kapha* and *Pitta*. *Acharya*

Vagbhata especially mentioned *Dadru* as *Anusangika*.Ayurvedic classics have

considered each type of *Kushtha* to be a *Tridoshaja* manifestation. Nonetheless,

their *Doshik* identity can established based on dominance of *Dosha* in the

*Samprapti*. Thus, *Dadru* is purely *Kaphaja* phenomenon. Based on presenting

symptomatology most of the scholars have similated *Dadru* with ’Fungal

dermatocytes through modern perspective. It comes under, superficial fungal

infections of the skin.

Globally, up to 20% of the population may be infected by ringworm at any given

time

AIMS AND OBJECTIVE:

To conduct a *Nidanatmaka* (survey) study to know the etiopathogenesis of ‘*Dadru*’

*Kushtha*.

To evaluate and compare the efficacy of *Guduchyadi Kwatha* & *Mulakadi Lepa* in

the management of ‘*Dadru*’ *Kushtha*.

HYPOTHESIS:

NULL HYPOTHESIS (H0): Trial drugs *Mulakadi Lepa* and *Guduchyadi kwatha*

are no difference in the management of ‘*Dadru’ Kushtha*

ALTERNATIVE HYPOTHESIS (H1): Trial drugs *Mulakadi Lepa* and *Guduchyadi*

*kwatha* are difference in the management of ‘*Dadru’ Kushtha*

Detailed Description

Not available

Study Timeline

• Study Start: 2020-10-07
• Last Update Posted: 2021-09-07
• Study Completion: 2021-12-03

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Patient with the classical sign and symptoms of Dadru Kushtha viz.
• kandu, raga, pidika and mandala.
• Patients 18 years to 60 years of age will be included.
• Patients belonging to either gender will be included.

Exclusion Criteria

• The patient suffering from severity systemic disorders will be excluded.
• The pregnant women and lactating mother will be excluded.
• Patient less than 18 yrs and above 60 yrs of age will be excluded.
• Skin malignancy and other skin diseases.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement in skin lesions (mandala).	30 days

Secondary Outcome Measures

Name	Time	Method
Improvement in the following signs and symptoms- kandu,raga, pidika	30 days

Trial Locations

Locations (1)

Arogyashala NIA; 🇮🇳 Jaipur, RAJASTHAN, India

Arogyashala NIA

🇮🇳Jaipur, RAJASTHAN, India

Dr Ravi Prakash Verma

Principal investigator

7976582140

rv29690@gmail.com